Immune boosting dietary supplements for adults recently diagnosed with COVID-19

Survey

Researchers in the nutrition and biodesign programs at Arizona State University (ASU) are conducting a research study to investigate the effects of natural food-based supplements on immune system responsiveness: curcumin (from turmeric) and palmitoylethanolamide (from egg yolk and peanuts). We are recruiting adults who recently tested positive for COVID-19 (less than 2 weeks) and displayed mild or no symptoms. We are inviting your participation in the screening process, which will consist of answering questions regarding health history, demographics, and scheduling availability. This research will require two visits to the test site located in the Arizona Biomedical Collaborative (ABC) building on the ASU downtown Phoenix campus for blood draws. You have the right not to answer any question, and to stop participation at any time. We are recruiting healthy adults ≥18 years of age. Your participation in this screening process is voluntary. If you choose not to participate or to withdraw from the survey at any time, there will be no penalty. Your responses to this survey will not be linked to your name but may be used in aggregate form for publications and presentations. If you meet the criteria for this study, you will be contacted for further screening. If you have any questions concerning the research study, please contact Samantha Fessler, a doctoral student in the nutrition program at ASU, at sfessler@asu.edu. You may also contact Dr. Carol Johnston, ASU Nutrition Professor who is leading this study at carol.johnston@asu.edu. If you have any questions about your rights as a subject/participant in this research, or if you feel you have been placed at risk, you can contact the Chair of the Human Subjects Institutional Review Board, through the ASU Office of Research Integrity and Assurance, at (480) 965-6788.

Completion of this survey will indicate your consent to participate in this screening. You will be contacted by investigators (via e-mail) to schedule an appointment, should you qualify.

Question Title

* 1. Please provide your email address.

Question Title

* 2. How old are you in years?

Question Title

* 3. Please select your gender.

Male

Female

Question Title

* 4. What is your height in inches? (5 feet = 60 inches) (6 feet = 72 inches)

Question Title

* 5. What is your current weight in pounds?

Question Title

* 6. Are you a student or employee at Arizona State University (ASU)?

Yes

Question Title

* 7. Have you tested positive for COVID-19?

Yes

Question Title

* 8. If you have tested positive for COVID-19, what was the date of your positive result? (write NA if you did not test positive for COVID-19)

Question Title

* 9. Have you been diagnosed with heart disease, stroke, diabetes, cancer, mood disorders, asthma, or other chronic illness?

Yes

Question Title

* 10. Are you currently taking any prescription medications for chronic conditions?

Yes

Question Title

* 11. Do you currently smoke (including vaping) or consume >14 alcoholic drinks per week?

Yes

Question Title

* 12. Are you allergic to any foods or supplements?

Yes

Question Title

* 13. If female, are you pregnant, planning on becoming pregnant within the next 6 months, or breastfeeding?

Yes

Not female

Question Title

* 14. Do you consider yourself healthy?

Yes

Question Title

* 15. Are you currently experiencing any respiratory tract symptoms or other symptoms linked to COVID-19?

Yes

Question Title

* 16. On average, how many minutes of moderate to vigorous physical activity do you perform weekly? (e.g., exercise that breaks a sweat)?

Question Title

* 17. Are you willing to meet with the investigators on the ASU downtown campus on two occasions to provide a blood sample?

Yes

Question Title

* 18. Are you willing to consume a dietary supplement in pill form (either curcumin or palmitoylethanolamide) or placebo daily for four weeks?

Yes

Question Title

* 19. How would you classify your COVID-19 illness?

Asymptomatic Infection: Individuals have no symptoms that are consistent with COVID-19.

Mild Illness: Individuals who have any of the various signs and symptoms of COVID-19 (e.g., fever, cough, sore throat, malaise, headache, muscle pain, nausea, vomiting, diarrhea, loss of taste and smell) but who do not have shortness of breath, dyspnea, or abnormal chest imaging.

Moderate Illness: Individuals who show evidence of lower respiratory disease during clinical assessment or imaging and who have an oxygen saturation (SpO2) ≥94% on room air at sea level.

Severe Illness: Individuals who have SpO2 <94% on room air at sea level and experience rapid clinical deterioration. Oxygen therapy is administered and antibiotics may be initiated. Patient may be hospitalized and is evaluated daily.

Critical Illness: Individuals who have respiratory failure, septic shock, and/or multiple organ dysfunction.

Question Title

* 20. If you have been vaccinated, which vaccine did you receive?

Johnson & Johnston

Pfizer

Moderna

Other

I have not been vaccinated

Question Title

* 21. If you have been vaccinated, what was the date of the final shot? (write NA if not vaccinated)

Question Title

* 22. Would you like us to contact you for future opportunities to participate in nutrition research at ASU?

Yes